48 results
Page 2 of 3
6-K
EX-99.1
673keww06dyatokc4j
9 Feb 21
SciSparc Initiates Commercial Production of its CannAmide™ Pills
8:36am
6-K
EX-99.1
4llb8t6can9
5 Jan 21
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada
9:12am
424B4
869rgt
20 Nov 20
Prospectus supplement with pricing info
4:43pm
FWP
24sj89mhf6 4fklyb
5 Nov 20
Free writing prospectus
5:11pm
F-1/A
8wolt
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
FWP
ptfba
21 Oct 20
Free writing prospectus
7:26am
F-1/A
b15aa6yvq8og8u
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
F-1/A
dm8bsgu4nq0k
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.2
7lj5z ogqjko
9 Oct 20
Interim Consolidated Financial Statements
12:00am
6-K
EX-99.1
f1tn8r7 5it2le7p
16 Sep 20
Developing cannabinoid based pharmaceuticals Corporate Presentation • September 2020
7:11am
F-1
5dbtjiwb
8 Sep 20
Registration statement (foreign)
5:31pm
6-K
EX-99.2
4fg0nm5 yc3y4e2tk
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
424B4
1pq7qyw
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
80kun
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
bly 4keg9
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
wty48m xmknvpp
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
770epwubub
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
424B5
xy4b2u
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-99.1
8zk84ub ulmhnta9sib
31 Jul 19
Therapix Biosciences Announces Canadian Product License Issuance for TheraPEA (CannAmide™), a Non-Opiate Based Pain Management Supplement
4:03pm